From the ∗Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim
†Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen
‡Department for Child and Adolescent Psychiatry, Neurology, Psychosomatics and Psychotherapy, Rostock University Medical Center, Rostock
§Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim
∥Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen
¶Department of Child and Adolescent Psychiatry, GGP Group, Rostock, Germany.
Received for publication February 14, 2022; accepted April 1, 2022.
Reprints: Sebastian Karl, MD, Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, 68159 Mannheim, Germany (e-mail: [email protected]).
(ORCID: 0000-0001-5406-7137)
(ORCID: 0000-0002-5612-2651)
(ORCID: 0000-0002-7738-4394)
(ORCID: 0000-0002-1243-3693)
S.K. and I.M. are shared first authors.
M.K. received funding by the German Ministry of Education and Research for several projects. He served in an advisory board for Janssen and received royalties from Springer, Hogrefe, and Beltz. The present work is unrelated to these relationships. L.P. was paid for public speaking by Takeda and Medice and received research funding from the EU, the German Research Society (DFG), and the Federal Ministry of Education and Research (BMBF). She receives royalties from Springer and Hogrefe. The present work is unrelated to these relationships. The other authors have no conflicts of interest or financial disclosures to report.
